Fiber scaffolds for use creating implantable structures
A synthetic construct suitable for implantation into a biological organism that includes at least one polymer scaffold; wherein the at least one polymer scaffold includes at least one layer of polymer fibers that have been deposited by electrospinning; wherein the orientation of the fibers in the at least one polymer scaffold relative to one another is generally parallel, random, or both; and wherein the at least one polymer scaffold has been adapted to function as at least one of a substantially two-dimensional implantable structure and a substantially three-dimensional implantable tubular structure.
1. A scaffold consisting of:
a layer of biocompatible electrospun polymer fibers having an orientation relative to one another that is generally parallel, random, or a combination thereof;
the scaffold having a shape selected from the group consisting of an arteriovenous shunt, a vascular implant, a stent, a conduit, and combinations thereof.
2. The scaffold of claim 1 , wherein the biocompatible electrospun polymer fibers comprise a non-resorbable material selected from the group consisting of polyethylene, polyethylene oxide, polyethylene terephthalate, polyester, polymethylmethacrylate, polyacrylonitrile, silicone, polyurethane, polycarbonate, polyether ketone ketone, polyether ether ketone, polyether imide, polyamide, polystyrene, polyether sulfone, polysulfone, polyvinyl acetate, and combinations thereof.
3. The scaffold of claim 1 , wherein the biocompatible electrospun polymer fibers comprise a resorbable material selected from the group consisting of polycaprolactone (PCL); polylactic acid (PLA); polyglycolic acid (PGA); polydioxanone (PDO); Poly(3- hydroxybutyrate-co-3-hydroxyvalerate) (PHBV); trimethylene carbonate (TMC); polydiols; and combinations thereof.
4. The scaffold of claim 1 , wherein the biocompatible electrospun polymer fibers comprise a natural polymer selected from the group consisting of collagen; gelatin; fibrin; fibronectin; albumin; hyaluronic acid; elastin; chitosan; alginate; and combinations thereof.
5. The scaffold of claim 1 , wherein the biocompatible electrospun polymer fibers have a diameter of about 100 nm to 50 μm and a pore size of about 100 nm to 250 μm.
6. The scaffold of claim 1 , wherein a surface of the biocompatible electrospun polymer fibers comprise features selected from the group consisting of pores, dimples, hairs, and combinations thereof.
7. A scaffold consisting of:
a layer of biocompatible electrospun polymer fibers having an orientation relative to one another is generally parallel, random, or a combination thereof;
the scaffold having a uniform thickness and a shape of an arteriovenous shunt;
wherein the scaffold varies in compliance from an arterial side to a venous side.
8. The scaffold of claim 7 , wherein the biocompatible electrospun polymer fibers comprise an elastomeric material selected from the group consisting of polyurethane; polycaprolactone; polyethylene terephthalate; polydioxanone; chitosan; and combinations thereof.
9. The scaffold of claim 7 , wherein the arteriovenous shunt is electrically conductive.
10. The scaffold of claim 7 , wherein the arteriovenous shunt has been modeled on actual patient anatomy.
11. The scaffold of claim 1 , having an increased degree of fiber alignment configured to increase burst pressure strength and decrease compliance.